impact factor, citescore
logo
 

Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983. The journal includes annual monothematic issues on the following topics:

The monothematic issue on Myositis is also the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics, once accepted are published ahead-of-print online, and subsequently included in the correspondent monothematic issue.

Editor-in-Chief
Stefano Bombardieri, MD

Environmental Rheumatology

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €130.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

Education and CME

 

last archive

Quality

The 5 most viewed PDFs in the last 7 days
in press from 6 months ago (One year in review excluded)

From 16/05/2025 to 23/05/2025

CER18707
Free to view
81 click

The long journey of artificial intelligence in medicine: an overview
E. Grossi

Rheumatology Abstract

 

CER17109
Free to view
74 click

STEp-down approach in MEthotrexate use for the Treatment of Rheumatoid Arthritis (STEMETRA): a pilot study demonstrating efficacy and safety of short-term, high dose methotrexate
M. Pendolino, T. Serban, G. Ferrari, P. Diana, A. Locaputo, D. Camellino, A. Giusti, G. Bianchi

Rheumatology Abstract

 

CER18234
Free to view
62 click

Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis
Q. Zhou, S. Zhu, S. Dai, Q. Wu, J. Zheng, H. Zhu, W. Yang

Rheumatology Abstract

 

CER17634
Free to view
61 click

A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients
Y. Yazici, J.R. Tambiah, C.J. Swearingen, V.A. Lopez, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon

Rheumatology Abstract

 

CER18105
Free to view
54 click

Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion
M. Manara, A. Carriero, M. Congia, C. Galluzzo, M. Pandolfi, M. Salvato, S. Scriffignano, A. Cauli, S. D'angelo, E. Lubrano, R. Ramonda, C. Salvarani, A. Marchesoni
Collaborator/s: F. Atzeni, C. Baldi, S. Bellando Randone, F. Caso, M.S. Chimenti

Rheumatology Abstract

 

The 5 most viewed Abstracts in the last 7 days
in press from 6 months ago (One year in review excluded)

From 16/05/2025 to 23/05/2025

CER18834
Free to view
241 click

Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis
A. Rossi, G. Ferrari, V. Galli, M. Bonacini, G. Carnevale, A. Pisciotta, R. Di Tinco, M. Catanoso, F. Brandolino, C. Galluzzo, A. Zerbini, C. Salvarani, S. Croci

Rheumatology Abstract

 

CER17109
Free to view
191 click

STEp-down approach in MEthotrexate use for the Treatment of Rheumatoid Arthritis (STEMETRA): a pilot study demonstrating efficacy and safety of short-term, high dose methotrexate
M. Pendolino, T. Serban, G. Ferrari, P. Diana, A. Locaputo, D. Camellino, A. Giusti, G. Bianchi

Rheumatology Abstract

 

CER18707
Free to view
170 click

The long journey of artificial intelligence in medicine: an overview
E. Grossi

Rheumatology Abstract

 

CER17634
Free to view
162 click

A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients
Y. Yazici, J.R. Tambiah, C.J. Swearingen, V.A. Lopez, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon

Rheumatology Abstract

 

CER18297
Free to view
158 click

Clinical outcomes in cancer patients with immune checkpoint inhibitor-induced arthritis treated with methotrexate: a retrospective longitudinal monocentric pilot study
E. Hysa, A. Casabella, N. Iandolino, E. Gotelli, C. Genova, E.T. Tanda, C. Pizzorni, V. Smith, A. Sulli, M. Cutolo, S. Paolino

Rheumatology Abstract